Skip to main content
SDGR
NASDAQ Life Sciences

Schrödinger Beats on Revenue Growth, Raises Full-Year ACV and Drug Discovery Outlook

Tom Rudovsky · Reported by BusinessWire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$28.72
Mkt Cap
$2.133B
52W Low
$10.945
52W High
$33.78
52W Position info
162% above low
Off High info
15% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SDGR has more than doubled off its 52-week low of $10.945.

Summary

Schrödinger posted Q3 total revenue of $64.5 million, up 19%, with drug discovery revenue nearly doubling to $24.2 million from $13.0 million on a Structure Therapeutics milestone. ACV rose 17% to $44.7 million and hosted software revenue jumped 49%, showing the shift to hosted licenses is landing. The company raised FY2026 ACV guidance to $222-232 million (12-17% growth) from $218-228 million and drug discovery revenue to $75-85 million from $65-75 million, while keeping opex below 2025. The offset: net loss widened to $37.7 million from $32.8 million, or 50 cents a share, driven by an $11.4 million other-expense swing from mark-to-market on equity holdings, not operations. Cash and marketable securities stand at $373 million. Updated Phase 1 data for SGR-1505 is set for an oral session at ASH, December 12-15, 2026, though the company corrected its ASH abstract to note that no combination study of SGR-1505 has been initiated under its FDA-cleared protocol, and it is exploring strategic options for the program.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Schrödinger corrected its ASH abstract: no combination study of SGR-1505 has been initiated under its FDA-cleared protocol, and it is exploring strategic options for the program.

At the time of this announcement, SDGR was trading at $28.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $10.95 to $33.78. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

SDGR - Latest Insights

SDGR
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.50
Real-time Price: $25.65 info
Change: -$3.85 (-13%) info
Market Cap: $1.978B info
SDGR
Nov 04, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.44
Real-time Price: $25.65 info
Change: -$5.79 (-18%) info
Market Cap: $1.978B info
SDGR
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.75
Real-time Price: $25.65 info
Change: -$5.10 (-17%) info
Market Cap: $1.978B info
SDGR
Sep 09, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $20.03
Real-time Price: $25.65 info
Change: +$5.62 (+28%) info
Market Cap: $1.978B info
SDGR
Aug 05, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $15.71
Real-time Price: $25.65 info
Change: +$9.94 (+63%) info
Market Cap: $1.978B info